Fact CheckerSign in

NCT06802159Recruiting

Rehabilitation Methods for Unilateral Spatial Neglect in Stroke Patients

A Comparative Analysis of Methods for Rehabilitation of Unilateral Spatial Neglect (USN) in Stroke Patients: Conventional Therapy, Computerized Cognitive Training and Eye Movement Biofeedback Training

Source: ClinicalTrials.gov · Last updated 22 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Stroke remains one of the leading causes of mortality and disability worldwide. Between 30% and 40% of patients who have had an acute cerebral hemorrhage, develop unilateral spatial neglect syndrome (USN). USN is observed in 24% of patients with left-hemispheric stroke and 45% of patients with right-hemispheric lesions in the acute phase acute phase and in 20% of patients in the chronic phase. The presence of USN significantly complicates the rehabilitation process and negatively affects the functional outcomes. The complexity of USN correction is due to the heterogeneity of its manifestations and combination with other cognitive disorders. In 30-50% of patients with USN anosognosia is observed, in 60% - memory and attention disorders. Traditional methods of rehabilitation lead to significant improvement in 30-50% of patients with USN. The use of combined methods of treatment, including pharmacotherapy and non-medication methods, can improve efficacy by up to 70-80%. This indicates the need to develop and investigate new approaches to correct USN. Despite the growing number of studies in this area, there is still no unified approach to selecting the optimal method of USN correction for each individual patient. Different methods of rehabilitation may have different effects on neuroplasticity processes, which opens new perspectives for optimization of rehabilitation strategies.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
27 Jan 2025
Start date
9 Jan 2025
Primary completion date
15 Jun 2025
Lead sponsor
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
Diseases
Stroke
NCT number
NCT06802159

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 9 Jan 2025 to the primary completion date, 15 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • the presence of gross oculomotor disorders;

Other

  • presence of mental and somatic pathology of severe degree and in decompensation stage;
  • presence of a sensory visual defect of moderate to severe severity

Who the study is looking for

  • Normal cognitive development in accordance with age and educational level;
  • diagnosis with codes I63, I61 (ICD);
  • presence of unilateral spatial neglect syndrome in the neuropsychological status.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Federal Center of Brain and Neurotechnologies of the FMBA of Russia
Coordinator of this site? Confirm its status
MoscowRussiaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.